Materials and methods
Materials and preparation of standard solutions
All chemicals and solvents were of the highest purity grade. Labelled and non-labelled standards used for quantification (See Table S1 for details) were purchased from SigmaAldrich (Isotec, Gillingham, UK), CK Isotope (Cambridge Isotope Laboratories, Ibstock, UK), ALSA CHIM (Illkirch, France), Biozol (Eching, Germany), TCI-UK (Oxford, UK), Alfa Aesar, TOCRIS (Bristol, UK) , and Acros Organics. Ultrapure HPLC-grade methanol and water were purchased from Sigma-Aldrich (Gillingham, UK).
The standard stock solutions were prepared taking into account all specifications of chemical purity and isotopic enrichment for labelled standards. For the most part, the labelled standard solutions were additionally prepared in deuterated methanol and assessed by 1 N isotope-labelled standards is preferential to deuterated standards in targeted analysis because the latter can interfere with the signal of targeted compound. 1 The stock solutions of the labelled and non-labelled standards were stored at 4 °C in tightly closed containers.
For the preparation of analyte-free matrix in the INTERMAP study, sodium borate solution in ultrapure HPLC-grade water at concentration of 10 g/L (as in the standard procedure for urine sample collection and storage in the INTERMAP project) was diluted 50 times to obtain similar borate concentration as expected in diluted urine samples. For the ARIC study, water with 0.01% of formic acid was used as an analyte-free matrix.
Chip based nanoelectrospray MS system
The nanoelectrospray was created and maintained by applying 1. Sodium formate solution was used to calibrate the mass spectrometer on a daily basis. The lock-mass function was turned off but data in both modes were recalibrated post-acquisition by in-house software using reference signals of endogenous metabolites present in all urine samples.
MS/MS was performed for targeted peaks in DIMS in Resolution mode in non-spiked pooled urine sample and pooled urine sample spiked with the standards. The optimal collision energy (CE) was selected for each peak between 10-60 eV. For the endogenous metabolites the spectra were compared to the spectra acquired for the standards in neat solvent and to the metabolite fragmentation patterns available in online databases (HMDB 2 and Metlin 3 ).
Synthetic Test Mixture (TM)
The TM consisted of glutamine, glutamic acid, creatinine, cytidine, citric acid, leucine, phenylalanine, tryptophan, hippuric acid, benzoic acid, and octanoic acid prepared at 25-100 μM concentration in ultrapure water.
For the analysis, the TM was diluted 10 times with ultrapure water. An aliquot of 50 μL was placed in a well and 100 μL of MeOH containing 0.015% of formic acid (final concentration of formic acid in a well was of 0.01%) were added to maintain 1:2 water-methanol proportion required for a stable nESI signal. The intra-day replicate analysis (n=10) of the TM was done in three separate days (total n=30), and the CV% of signal intensities was assessed intra-and inter-day without and with normalisation (to the sum of the intensities of targeted peaks). The TM was also analysed in two separate days (n=8) to estimate the effect of instrument maintenance (mass spectrometer venting after the nitrogen gas supply shutdown event with subsequent detector setup and chip-alignment procedure in the ChipSoft software) on the signal stability.
Parallel assay -standard addition vs. external calibration curves
In this work, the MS quantification was performed by the back-calculation of the ratio of each selected metabolite to its internal standard and the slope of the calibration curve obtained for that metabolite in the pooled urine sample. In order to show the reliability of our method, we compared the method of standard additions using the pooled urine sample as a matrix with the method of external calibration in the analyte-free matrix. For the INTERMAP study, the solution of boric acid of the same concentration as expected in the urinary specimens was prepared and used as an analyte-free matrix. The accuracy of metabolite quantification by both approaches was tested using the validation QC samples prepared at three different levels of concentrations defined for each metabolite from the corresponding linear range ( 
Analysis of Test Mixture
The TM was analysed over three days to assess intra-(n=10) and inter-day (n=30) variability of signal intensities. and subsequent venting of mass spectrometer followed by detector set-up and chip-alignment procedure for the nESI source. Figure S -9(B) shows the normalised intensity values for the n=8 measurements done before and after the instrument maintenance. The CV% values for all the analytes measured in positive and negative ion mode did not exceed 20 which is an acceptable metabolite precision providing the normalisation was done for targeted analytes.
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Supplementary Tables Japan  81  85  118  115  124  105  5  17  9  26  17  25   Benzoic Acid  USA  102  99  117  114  125  121  13  13  13  19  13  19   Japan  109  108  110  104  120  107  2  6  8  11  14  27   Caffeic acid  USA  107  105  111  112  128  125  2  24  1  28  1  29   Japan  114  110  97  95  115  109  2  23  6  22  8  25   Carnitine  USA  115  110  104  107  125  117  9  10  10  9  15  17   Japan  104  103  84  85  83  81  7  6  10  11  15  15   Cholic acid  USA  104  106  89  95  97  96  4  2  1  13  2  3 Table S-7. In-study validation as inter-day relative error (RE%) of measured concentration and precision values for metabolites measured in positive and negative ion modes in validation QC samples from the ARIC study. S-18 Isovalerylglycine  14%  10%  14%  16%  12%  8%  8%  10%  9%  10%  8%  9%  8%  13%   2-oxoglutaric acid  28%  >30%  27%  >30%  25%  30%  29%  27%  >30%  30%  >30%  22%  22%  22%   Ketoleucine  23%  >30%  25%  26%  14%  22%  11%  23%  24%  27%  28%  23%  12%  16%   Leucine  26%  24%  25%  18%  22%  12%  15%  13%  19%  16%  14%  11%  10%  11%   N-acetylneuraminic acid  19%  11%  21%  14%  20%  10%  15%  11%  15%  12%  11%  9%  9%  13%   Phenylacetylglutamine  21%  20%  18%  >30%  21%  18%  21%  11%  22%  20%  16%  13%  13%  21%   Saccharin  19%  15%  18%  19%  23%  10%  21%  12%  17%  15%  14%  11%  10%  15%   Succinic acid  20%  25%  25%  25%  14%  16%  8%  16%  14%  17%  11%  14%  10%  17%   Vanillylmandelic acid  16%  11%  17%  11%  14%  10%  13%  11%  10%  9%  9%  11%  9%  15%   Acetylcarnitine  17%  20%  17%  25%  17%  17%  12%  15%  18%  20%  24%  16%  10%  18%   Carnitine  8%  18%  15%  23%  13%  17%  11%  14%  13%  20%  23%  13%  9%  15%   S-19   Cotinine  23%  16%  19%  21%  21%  15%  17%  10%  7%  14%  19%  10%  5%  14%   Creatine  22%  26%  23%  29%  23%  20%  19%  15%  21%  20%  25%  11%  11%  13%   Creatinine  19%  21%  19%  29%  19%  21%  19%  18%  18%  24%  27%  17%  14% S-20 
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Figure S-6. Precision (as CV %) of slope values and concentration of the QC samples for some metabolites measured in Japan-F pooled urine samples from three validation series prepared and measured to assess the assay stability (freshly prepared, three freeze-thaw cycles, long-term storage at -80°C). Figure S-7. Concentration values of nicotine (A), acetylcarnitine (B) , and creatinine (C) measured in positive ion mode, and of caffeic acid (D), glutamic acid (E), and hippuric acid (F) measured in negative ion mode in the pooled SR samples in 11 batches from the USA-F population of the INTERMAP study. The straight lines represent the mean concentration ± 2 standard deviation. 
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Figure S-9. Test Mixture (TM) analysis: inter-day CV% (n=30) values for the intensities of compounds measured in negative ion mode and the effect of signal normalisation to the sum of intensities (A). CV% of normalised intensity values for the n=8 measurements done before and after the instrument maintenance (B). 
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